We are live on ! Find out more
CCM

Copernicus Capital Management Portfolio holdings

AUM $8.26M
1-Year Est. Return 37.91%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+37.91%
3 Year Est. Return
+125.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$8.83M
Cap. Flow
-$9.14M
Cap. Flow %
-7.28%
Top 10 Hldgs %
68.49%
Holding
30
New
7
Increased
6
Reduced
7
Closed
10

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$10.7M
2
GILD icon
Gilead Sciences
GILD
+$9.26M
3
TMO icon
Thermo Fisher Scientific
TMO
+$9.24M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$5.98M
5
BIIB icon
Biogen
BIIB
+$4.65M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$10.3M
2
HOLX
Hologic
HOLX
+$9.41M
3
PBYI icon
Puma Biotechnology
PBYI
+$6.5M
4
EVHC
Envision Healthcare Holdings Inc
EVHC
+$6.08M
5
TSRO
TESARO, Inc.
TSRO
+$5.3M

Sector Composition

Rank Sector Weight
1 Healthcare 97.21%
2 Consumer Discretionary 2.79%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTLA
26
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-59,149
Closed -$2.88M
TSRO
27
DELISTED
TESARO, Inc.
TSRO
– –
-64,000
Closed -$5.3M
AET
28
DELISTED
Aetna Inc
AET
– –
-57,291
Closed -$10.3M
EVHC
29
DELISTED
Envision Healthcare Holdings Inc
EVHC
– –
-176,000
Closed -$6.08M
BEAT
30
DELISTED
BioTelemetry, Inc.
BEAT
– –
-70,000
Closed -$2.09M
1
2

Similar funds

AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Copernicus Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Copernicus Capital Management held 30 positions worth $125M, down 6.6% from $134M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Copernicus Capital Management withdrew a net $9.14M in Q1 2018, closing 10 positions and reducing 7 holdings. Its most notable exit was Aetna Inc, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Copernicus Capital Management opened a new position in Cigna worth $9.23M.

  • Copernicus Capital Management's largest Q1 2018 buy was Cigna: 55,000 shares worth $9.23M.
  • Copernicus Capital Management added most to Biogen in Q1 2018, an estimated $4.65M increase.
  • Copernicus Capital Management's biggest Q1 2018 reduction was Edwards Lifesciences, cutting an estimated $3.63M.
  • Copernicus Capital Management fully exited Aetna Inc in Q1 2018, selling an estimated $10.3M.
  • Copernicus Capital Management's ten largest holdings make up 68% of its $125M portfolio in Q1 2018.
  • Copernicus Capital Management opened 7 new positions and closed 10 in Q1 2018.
  • Copernicus Capital Management's portfolio value fell 6.6% quarter-over-quarter to $125M.

Based on Copernicus Capital Management's 13F filing for Q1 2018, filed 1 May 2018.